We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new and expensive anti-fungal drug to treat vaginal yeast infections was approved by the U.S. Food and Drug Administration this week, but critics say it's not needed.